We are Juno –
an Australian team of innovative thinkers,
passionate about supporting hospitals and
healthcare specialists with industry leading,
off-patent pharmaceuticals.

Company NEWS

Amneal Portfolio Acquisition

Juno Pharmaceuticals today announced it has acquired the Amneal injectables, ophthalmic, and oncology portfolio. This business primarily has a focus on Australian hospital customers. Read more

Product NEWS

Juno Pharmaceuticals and Amgen Australia announce partnership for the marketing and distribution of biologic medicines Neulasta® (Pegfilgrastim) and Ristempa® (Pegfilgrastim) in Australia.

MELBOURNE, AUSTRALIA – Juno Pharmaceuticals is pleased to announce that Amgen Australia have appointed us as their distribution partner for the exclusive marketing and distribution of Amgen’s biologic medicines Neulasta (Pegfilgrastim) and the launch of Ristempa (Pegfilgrastim). Read more

Our Products

Know what product you're looking for or need help with your search? Just use the search function below to find it by product name or category.


Partnering with Juno

Working with the right partners is key for us. It means that we can deliver our products as quickly and efficiently as possible to hospitals and healthcare specialists.

For our partners, it’s our competitive edge as a privately owned Australian business, our understanding of the Australian and New Zealand hospital markets, our collaborative outlook and innovative approach that sets us apart.

Learn more